文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.

作者信息

Park Sang Joon, Jang Jae Young, Jeong Soung Won, Cho Young Kyu, Lee Sae Hwan, Kim Sang Gyune, Cha Sang-Woo, Kim Young Seok, Cho Young Deok, Kim Hong Soo, Kim Boo Sung, Park Suyeon, Bang Hae In

机构信息

Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine, College of Medicine, Soonchunhyang University, Seoul Department of Internal Medicine, College of Medicine, Soonchunhyang University, Cheonan Department of Internal Medicine, College of Medicine, Soonchunhyang University, Bucheon Biostatistical Consulting Unit Department of Laboratory Medicine, Soonchunhyang University, Seoul, Republic of Korea.

出版信息

Medicine (Baltimore). 2017 Mar;96(11):e5811. doi: 10.1097/MD.0000000000005811.


DOI:10.1097/MD.0000000000005811
PMID:28296720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5369875/
Abstract

Alpha-fetoprotein (AFP), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3), and protein induced by vitamin K absence or antagonist-II (PIVKA-II) are widely used as tumor markers for the diagnosis of hepatocellular carcinoma (HCC). This study compared the diagnostic values of AFP, AFP-L3, and PIVKA-II individually and in combination to find the best biomarker or biomarker panel.Seventy-nine patients with newly diagnosed HCC and 77 non-HCC control patients with liver cirrhosis were enrolled. AFP, AFP-L3, and PIVKA-II were measured in the same serum samples using microchip capillary electrophoresis and a liquid-phase binding assay on an automatic analyzer. Receiver-operating characteristic curve analyses were also applied to all combinations of the markers.When the 3 biomarkers were analyzed individually, AFP showed the largest area under the receiver-operating characteristic curve (AUC) (0.751). For combinations of the biomarkers, the AUC was highest (0.765) for "PIVKA-II > 40 mAU/mL and AFP > 10 ng/mL." The combination of "PIVKA-II > 40 mAU/mL and AFP > 10 ng/mL and AFP-L3 > 10%" had worse sensitivity and lower AUC (P = 0.001). The highest AUC of a single biomarker was highest for AFP and of a combination was "PIVKA-II > 40 mAU/mL and AFP > 10 ng/mL," with this also being the case when the cut-off value of AFP and AFP-L3 was changed.Alpha-fetoprotein showed the best diagnostic performance as a single biomarker for HCC. The diagnostic value of AFP was improved by combining it with PIVKA-II, but adding AFP-L3 did not contribute to the ability to distinguish between HCC and non-HCC liver cirrhosis. These findings were not altered when the cut-off value of AFP and AFP-L3 was changed.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/4e7c62706d8f/medi-96-e5811-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/b042162e5e9f/medi-96-e5811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/f9378d221357/medi-96-e5811-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/688c992db60c/medi-96-e5811-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/4e7c62706d8f/medi-96-e5811-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/b042162e5e9f/medi-96-e5811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/f9378d221357/medi-96-e5811-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/688c992db60c/medi-96-e5811-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5369875/4e7c62706d8f/medi-96-e5811-g008.jpg

相似文献

[1]
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.

Medicine (Baltimore). 2017-3

[2]
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.

World J Gastroenterol. 2013-1-21

[3]
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.

Scand J Gastroenterol. 2016-3

[4]
Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis.

Hepatobiliary Pancreat Dis Int. 2022-12

[5]
agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma.

World J Gastroenterol. 2021-7-28

[6]
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.

BMC Cancer. 2021-4-13

[7]
Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.

J Gastroenterol. 2007-12

[8]
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.

Panminerva Med. 2017-6-23

[9]
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.

World J Gastroenterol. 2015-4-7

[10]
Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.

Cancer Biomark. 2018

引用本文的文献

[1]
Circular RNAs as Biomarkers in the Diagnosis of Human Diseases.

Adv Exp Med Biol. 2025

[2]
DCP as a biomarker for TACE efficacy in hepatocellular carcinoma.

Front Oncol. 2025-7-28

[3]
Glycosylation in Cancer.

Handb Exp Pharmacol. 2025

[4]
Prediction of PD-1 Expression and Outcomes of Combined Therapy in Hepatocellular Carcinoma: an MRI-Based Radiomics Approach.

J Imaging Inform Med. 2025-5-12

[5]
The GALAD score performs better than AFP in hepatocellular carcinoma screening: a single-centre, case-control study in Malaysia.

Clin Exp Hepatol. 2025-3

[6]
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer.

J Hepatocell Carcinoma. 2025-3-6

[7]
Strategies for discovering novel hepatocellular carcinoma biomarkers.

World J Hepatol. 2025-2-27

[8]
Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis.

J Hepatocell Carcinoma. 2025-2-21

[9]
Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies.

JHEP Rep. 2024-11-8

[10]
Unlocking the diagnostic potential of vascular endothelial growth factor and interleukin-17: Advancing early detection strategies for hepatocellular carcinoma.

World J Gastrointest Surg. 2024-11-27

本文引用的文献

[1]
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013.

Cancer Res Treat. 2016-4

[2]
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma.

Onco Targets Ther. 2015-12-31

[3]
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.

Scand J Gastroenterol. 2016-3

[4]
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.

J Hepatol. 2014-11-11

[5]
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

Cancer. 2014-4-10

[6]
Update on biomarkers of hepatocellular carcinoma.

Clin Gastroenterol Hepatol. 2015-2

[7]
Japan's Successful Model of Nationwide Hepatocellular Carcinoma Surveillance Highlighting the Urgent Need for Global Surveillance.

Liver Cancer. 2012-11

[8]
Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region.

J Gastroenterol. 2013-3-6

[9]
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.

World J Gastroenterol. 2013-1-21

[10]
Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.

Oncol Rep. 2012-11-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索